SCHEMBL22985172

SCHEMBL22985172

N#Cc1ccc(-n2c3ccccc3c3cc(-c4ccccc4C#N)ccc32)c(-c2cc(-n3c4ccccc4c4cc(-c5ccccc5C#N)ccc43)ccc2-c2ccc(C(F)(F)F)cc2C#N)c1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5AP P20292 2/20 0.35
FEN1 P39748 2/20 0.35
NR3C1 P04150 1/20 0.35
PTPN5 P54829 1/20 0.33
GABRA1 P14867 2/20 0.32
GABRG2 P18507 2/20 0.32
GABRB3 P28472 2/20 0.32
GABRA5 P31644 2/20 0.32
GABRA3 P34903 2/20 0.32
AR P10275 1/20 0.31
KIF11 P52732 1/20 0.31
MC2R Q01718 1/20 0.30
KDM4E B2RXH2 1/20 0.30
MEN1 O00255 1/20 0.30
LMNA P02545 1/20 0.30
CYP1A2 P05177 1/20 0.30
CYP3A4 P08684 1/20 0.30
MAPT P10636 1/20 0.30
HPGD P15428 1/20 0.30
KMT2A Q03164 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22985171 0.97 ALOX5AP (0.37) ALOX5APFEN1NR3C1PTPN5GABRA1
SCHEMBL22985211 0.97 ALOX5AP (0.36) ALOX5APFEN1NR3C1KIF11PDPK1
SCHEMBL20848906 0.93 AR (0.34) ALOX5APFEN1NR3C1PTPN5GABRA1
SCHEMBL22985168 0.93 KIF11 (0.36) ALOX5APFEN1PTPN5ARKIF11
SCHEMBL22985616 0.93 AR (0.40) ALOX5APFEN1ARKIF11
SCHEMBL22985138 0.92 AR (0.34) ALOX5APFEN1ARKIF11
SCHEMBL22985063 0.92 KIF11 (0.33) ALOX5APFEN1PTPN5ARKIF11
SCHEMBL22985137 0.92 ALOX5AP (0.38) ALOX5APFEN1NR3C1PTPN5GABRA1
SCHEMBL22985468 0.92 KIF11 (0.33) ALOX5APFEN1ARKIF11
SCHEMBL22985618 0.92 KIF11 (0.33) ALOX5APFEN1ARKIF11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10919880-B2 Organic molecules, in particular for use in optoelectronic devices CYNORA GMBH (DE) 2021-02-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10919880-B2 Organic molecules, in particular for use in optoelectronic devices OCIAD1, OCIAD2, POU2F1 ALOX5AP 2567/4885FEN1 2939/4885NR3C1 4745/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.